Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
Japan flag Japan · Delayed Price · Currency is JPY
296.00
+10.00 (3.50%)
At close: Mar 5, 2026

Taiko Pharmaceutical Cash Flow Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
923565-3,563-4,869-8,887
Depreciation & Amortization
265256704737941
Loss (Gain) From Sale of Assets
62402,430982,456
Asset Writedown & Restructuring Costs
20----
Loss (Gain) From Sale of Investments
-347-6-19376-60
Other Operating Activities
-76171-602-1,101-1,023
Change in Accounts Receivable
-23-411-1752,3153,899
Change in Inventory
57-3015811,2573,222
Change in Accounts Payable
77-150308-1,177-2,932
Change in Other Net Operating Assets
-88-2203670789
Operating Cash Flow
814362-307-1,994-1,595
Operating Cash Flow Growth
124.86%----
Capital Expenditures
-291-157-97-64-1,476
Sale of Property, Plant & Equipment
--1702-
Cash Acquisitions
----9-107
Sale (Purchase) of Intangibles
-13-30-17-20-124
Investment in Securities
4472661,10528385
Other Investing Activities
-1-845-2-
Investing Cash Flow
142-51,166190-1,622
Long-Term Debt Issued
--500-5,000
Long-Term Debt Repaid
-1,226-1,206-1,053-923-316
Net Debt Issued (Repaid)
-1,226-1,206-553-9234,684
Issuance of Common Stock
-592,132-101
Common Dividends Paid
--1-1--782
Other Financing Activities
-1-33-39-74-44
Financing Cash Flow
-1,227-1,1811,539-9973,959
Foreign Exchange Rate Adjustments
-5112497682
Miscellaneous Cash Flow Adjustments
---1-1
Net Cash Flow
-276-7122,447-2,724823
Free Cash Flow
523205-404-2,058-3,071
Free Cash Flow Growth
155.12%----
Free Cash Flow Margin
8.18%3.26%-6.60%-40.83%-27.18%
Free Cash Flow Per Share
10.414.08-8.53-47.20-70.58
Cash Interest Paid
588106
Cash Income Tax Paid
3430-231,030
Levered Free Cash Flow
368.75-328.25470.25721-656.63
Unlevered Free Cash Flow
371.88-323.25475.25727.25-652.88
Change in Working Capital
23-8649173,0654,978
Source: S&P Global Market Intelligence. Standard template. Financial Sources.